GeoSeeq

Biotia Gets First-Ever NY State Regulatory Approval for a Urine Infectious Disease Test Powered by Genomics and AI We are thrilled to share big news at Biotia! After years of development and regulatory review, our BIOTIA-ID Urine NGS Assay has received New York State Department of Health regulatory approval! This is a major milestone for Biotia, as well as clinicians and patients seeking cutting-edge UTI tests which are more informative and accurate. This is especially important for patients suffering from recurrent or complicated UTIs. More about the test: - Unmatched Accuracy: 97% sensitivity and 99% specificity, far surpassing traditional methods. - AI-Powered: Our advanced machine learning algorithms deliver rapid and precise results. - Comprehensive: Identifies a broader range of pathogens, including those often missed by culture. Learn more about BIOTIA-ID and its potential to transform UTI diagnostics: https://lnkd.in/emQGZy6w #UTI #diagnostics #womenshealth #precisionmedicine #AI #innovation #healthcare

Scientists can now analyze genetic sequences from recent bird flu outbreaks in dairy cows directly in GeoSeeq. This crucial data enables assessment of potential mammalian risks associated with H5N1. https://lnkd.in/gT2ZCsmC #birdflu #H5N1 #publichealth #infectiousdisease David Danko Dorottya Nagy-Szakal MD PhD Niamh B. O'Hara

USDA releases crucial H5N1 bird flu genetic data from dairy cows. Scientists can now assess potential risks to mammals. Analytical work is underway – stay tuned for updates as data becomes available on GeoSeeq. #H5N1 #birdflu #publichealth

Great article about the potential of environmental DNA (eDNA) for disease surveillance! This innovative approach uses genetic material collected from the environment to track the spread of pathogens, potentially allowing us to stop outbreaks before they cause widespread harm. Geoseeq (thanks for the shoutout), the platform hosting Dr. Christopher Mason's lab MetaSub data, is at the forefront of eDNA analysis, monitoring for pathogens in wastewater, helping communities stay ahead of potential outbreaks. This is a game-changer for public health, and we are excited to see how eDNA technology continues to develop. And if you're interested in learning more about Geoseeq's work, check out our website! www.geoseeq.com #eDNA #PublicHealth #Geoseeq #FutureofHealthcare

Our CEO, Dr. Niamh B. O'Hara and Head of Business Development, Dr. Michael Benzinou will be sharing their expertise at the #AGU23 conference today, both virtually and in-person, alongside Dr. Charlie Vorosmarty, Dr. Angela Rasmussen, and Rick Lawford. Together, they will be discussing how valuable interdisciplinary collaborations can augment insights around climate-sensitive infectious diseases. Session details for those who are attending: Title: Town Hall TH33D: The Role of Earth System Science Data and Frameworks in an Early Warning System for Global Pandemics When: Wednesday December 13th 2023 13:00 - 14:00 PST in the Moscone Center, Room: 2016 – West, or online for those joining remotely.

Our Chief Medical Officer, Dorottya Nagy-Szakal MD PhD, is currently attending #PNAM2023 in Tunis! What an honor it is to be a part of such a special and important event.